These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

554 related articles for article (PubMed ID: 16674804)

  • 1. Melatonin in Alzheimer's disease and other neurodegenerative disorders.
    Srinivasan V; Pandi-Perumal SR; Cardinali DP; Poeggeler B; Hardeland R
    Behav Brain Funct; 2006 May; 2():15. PubMed ID: 16674804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melatonin in mitochondrial dysfunction and related disorders.
    Srinivasan V; Spence DW; Pandi-Perumal SR; Brown GM; Cardinali DP
    Int J Alzheimers Dis; 2011; 2011():326320. PubMed ID: 21629741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melatonin and its agonist ramelteon in Alzheimer's disease: possible therapeutic value.
    Srinivasan V; Kaur C; Pandi-Perumal S; Brown GM; Cardinali DP
    Int J Alzheimers Dis; 2010 Dec; 2011():741974. PubMed ID: 21197086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melatonin and mitochondrial dysfunction in the central nervous system.
    Cardinali DP; Pagano ES; Scacchi Bernasconi PA; Reynoso R; Scacchi P
    Horm Behav; 2013 Feb; 63(2):322-30. PubMed ID: 22391273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
    Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
    Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melatonin: A Potential Anti-Oxidant Therapeutic Agent for Mitochondrial Dysfunctions and Related Disorders.
    Ganie SA; Dar TA; Bhat AH; Dar KB; Anees S; Zargar MA; Masood A
    Rejuvenation Res; 2016 Feb; 19(1):21-40. PubMed ID: 26087000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotective Potential of Melatonin: Evaluating Therapeutic Efficacy in Alzheimer's and Parkinson's Diseases.
    Talbot NC; Luther PM; Spillers NJ; Ragland AR; Kidder EJ; Kelkar RA; Varrassi G; Ahmadzadeh S; Shekoohi S; Kaye AD
    Cureus; 2023 Dec; 15(12):e50948. PubMed ID: 38259379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melatonin in Alzheimer's Disease: A Latent Endogenous Regulator of Neurogenesis to Mitigate Alzheimer's Neuropathology.
    Hossain MF; Uddin MS; Uddin GMS; Sumsuzzman DM; Islam MS; Barreto GE; Mathew B; Ashraf GM
    Mol Neurobiol; 2019 Dec; 56(12):8255-8276. PubMed ID: 31209782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Involvement of Melatonin and Tasimelteon against Alzheimer's Disease.
    Ravikumar M; Mohan S; Velpandian C
    Curr Drug Saf; 2023; 18(3):284-296. PubMed ID: 35585820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melatonin and Autophagy in Aging-Related Neurodegenerative Diseases.
    Luo F; Sandhu AF; Rungratanawanich W; Williams GE; Akbar M; Zhou S; Song BJ; Wang X
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32998479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Melatonin in Aluminum-Related Neurodegenerative Disorders: a Review.
    Esparza JL; Gómez M; Domingo JL
    Biol Trace Elem Res; 2019 Mar; 188(1):60-67. PubMed ID: 29732485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melatonin Attenuates Memory Impairment, Amyloid-β Accumulation, and Neurodegeneration in a Rat Model of Sporadic Alzheimer's Disease.
    Rudnitskaya EA; Muraleva NA; Maksimova KY; Kiseleva E; Kolosova NG; Stefanova NA
    J Alzheimers Dis; 2015; 47(1):103-16. PubMed ID: 26402759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial effects of melatonin in experimental models of Alzheimer disease.
    Cheng Y; Feng Z; Zhang QZ; Zhang JT
    Acta Pharmacol Sin; 2006 Feb; 27(2):129-39. PubMed ID: 16412260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melatonin treatment restores mitochondrial function in Alzheimer's mice: a mitochondrial protective role of melatonin membrane receptor signaling.
    Dragicevic N; Copes N; O'Neal-Moffitt G; Jin J; Buzzeo R; Mamcarz M; Tan J; Cao C; Olcese JM; Arendash GW; Bradshaw PC
    J Pineal Res; 2011 Aug; 51(1):75-86. PubMed ID: 21355879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antioxidants and neuroprotection in the adult and developing central nervous system.
    Kaur C; Ling EA
    Curr Med Chem; 2008; 15(29):3068-80. PubMed ID: 19075654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial abnormalities in neurodegenerative models and possible interventions: Focus on Alzheimer's disease, Parkinson's disease, Huntington's disease.
    Pantiya P; Thonusin C; Chattipakorn N; Chattipakorn SC
    Mitochondrion; 2020 Nov; 55():14-47. PubMed ID: 32828969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent developments of melatonin related antioxidant compounds.
    Suzen S
    Comb Chem High Throughput Screen; 2006 Jul; 9(6):409-19. PubMed ID: 16842222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melatonin Therapy in Patients with Alzheimer's Disease.
    Cardinali DP; Vigo DE; Olivar N; Vidal MF; Brusco LI
    Antioxidants (Basel); 2014 Apr; 3(2):245-77. PubMed ID: 26784870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melatonin and Parkinson's disease.
    Mayo JC; Sainz RM; Tan DX; Antolín I; Rodríguez C; Reiter RJ
    Endocrine; 2005 Jul; 27(2):169-78. PubMed ID: 16217130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of melatonin in Alzheimer's disease.
    Cardinali DP; Brusco LI; Liberczuk C; Furio AM
    Neuro Endocrinol Lett; 2002 Apr; 23 Suppl 1():20-3. PubMed ID: 12019347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.